Leveraging rare genetic variation to understand the role of Liver X Receptor in human glucose and lipid metabolism (360G-Wellcome-225479_Z_22_Z)
Genes are the instruction manual of our cells. They contain the code (in the form of DNA) that enables our cells to make all that is necessary to function. Small changes in our genes can have a large impact on our risk of disease. This is well known for rare inherited diseases like cystic fibrosis. However, it is also the case that a proportion of common diseases, like Type 2 diabetes and cardiovascular disesae, may be the result of damaging mutations in certain genes. Liver X Receptor-alpha (LXR-alpha) is a protein that senses cholesterol in our liver and fat tissue, however, it is unclear if LXR-alpha has any effect on blood sugar or the lipids in our blood. We will identify humans in population biobanks with rare changes that effect Liver X receptor function and compare them to those who do not carry these changes to help inform the function of Liver X Receptor in humans. We will use bespoke mouse models with a specific loss of function mutation in Liver X Receptor and cell models grown in test tubes to probe the specific mechanisms that underlie the effects of Liver X Receptor identified in human studies.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.